Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat

被引:28
|
作者
King, CMF
Gommans, J
Joordens, RJE
Hijzen, TH
Maes, RAA
Olivier, B
机构
[1] UNIV UTRECHT,FAC PHARM,DEPT PSYCHOPHARMACOL,NL-3584 CA UTRECHT,NETHERLANDS
[2] UNIV UTRECHT,RUDOLF MAGNUS INST NEUROSCI,NL-3584 CA UTRECHT,NETHERLANDS
[3] UNIV UTRECHT,FAC PHARM,DEPT TOXICOL,NL-3584 CA UTRECHT,NETHERLANDS
关键词
5-HT1A receptor; 8-OH-DPAT(8-hydroxy-2-(di-n-propylamino)tetralin); flesinoxan; WAY-100635; anxiety; Geller-Seifter; conflict; (rat);
D O I
10.1016/S0014-2999(97)00114-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a modified Geller-Seifter conflict procedure, rats were trained to lever-press for food under a multiple variable interval-fixed ratio (VI30: food; FRIO: food + shock) schedule of reinforcement. The ability to antagonize response suppression in the punished period is considered a good predictor for anxiolytic activity. Chlordiazepoxide and alprazolam increased punished responding. The 5-HT1A receptor agonists flesinoxan (R(+)-N-[2[4-(2,3-dihydro-2-2-hydroxymethyl-1,4-benzodioxin-5-yl)-1-piperazinyl]ethyl]-4-fluorobenzoamide; 0.1-10.0 mg/kg) and 8-OH-DPAT (8-hydroxy-2-(di-n-propyl-amino)tetralin; 0.03-0.5 mg/kg) significantly increased punished re spending, supporting a role of the 5-HT1A receptor in anxiety. 8-OH-DPAT and flesinoxan also reduced unpunished responding. The anxiolytic effects of 8-OH-DPAT and flesinoxan could only be antagonized with a high dose (1.0 and 3.0 mg/kg respectively) of the 5-HT1A receptor antagonist WAY-100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride). All doses of WAY-100635 antagonized the 5-HT1A-induced effects on unpunished responding. The dissimilarity in dose-response curve of WAY-100635 on punished and unpunished behaviour poses questions about the mediation of these effects. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 50 条
  • [41] NEUROANATOMICAL CORRELATE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF THE 5-HT1A RECEPTOR LIGANDS 8-OH-DPAT AND IPSAPIRONE IN THE RAT
    DEVRY, J
    SCHREIBER, R
    PSYCHOPHARMACOLOGY, 1990, 101 : S67 - S67
  • [42] NEUROANATOMICAL CORRELATE OF THE ANXIOLYTIC EFFECTS OF THE 5-HT1A RECEPTOR LIGANDS 8-OH-DPAT, IPSAPIRONE AND BUSPIRONE IN THE RAT
    SCHREIBER, R
    DEVRY, J
    PSYCHOPHARMACOLOGY, 1990, 101 : S52 - S52
  • [43] The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response
    R. J. E. Joordens
    T. H. Hijzen
    B. Olivier
    Psychopharmacology, 1998, 139 : 383 - 390
  • [44] The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response
    Joordens, RJE
    Hijzen, TH
    Olivier, B
    PSYCHOPHARMACOLOGY, 1998, 139 (04) : 383 - 390
  • [45] 5-HT1A antagonist augments the anti-apoptotic actions of 5-HT1A receptor agonist in rat hippocampus
    Vazzana, JT
    Nogueira, MI
    Samtani, N
    Azmitia, EC
    FASEB JOURNAL, 2003, 17 (05): : A1181 - A1181
  • [46] ARE THERE SELECTIVE LIGANDS FOR 5-HT1A AND 5-HT1B RECEPTOR-BINDING SITES IN BRAIN
    HAMON, M
    COSSERY, JM
    SPAMPINATO, U
    GOZLAN, H
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (09) : 336 - 338
  • [47] High potent and selective arylpiperazine derivatives as ligands for the 5-HT1A receptor
    Modica, M
    Santagati, M
    Santagati, A
    Russo, F
    Cagnotto, A
    Goegan, M
    Mennini, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) : 1089 - 1092
  • [48] Novel trisubstituted oxazole derivatives as 5-HT1A receptor ligands.
    Greenblatt, LP
    Nelson, FC
    Kelly, MG
    Smith, DL
    Schechter, LE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U557 - U557
  • [49] Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands
    Walory, Jaroslaw
    Mielczarek, Lidia
    Jaronczyk, Malgorzata
    Koronkiewicz, Miroslawa
    Kossakowski, Jerzy
    Bugno, Ryszard
    Bojarski, Andrzej J.
    Chilmonczyk, Zdzislaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [50] 5-HT1A receptor ligands and their therapeutic applications: review of new patents
    Staron, Jakub
    Bugno, Ryszard
    Hogendorf, Adam S.
    Bojarski, Andrzej J.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (09) : 679 - 689